CoChat

Short‐Term, High‐Dose Fish Oil Supplementation Increases the Production of Omega‐3 Fatty Acid–Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA‐PAD I Trial)

Open access
Grenon, S. Marlene, Owens, Christopher D., Nosova, Emily V., Hughes‐Fulford, Millie, Alley, Hugh F., Chong, Karen, Perez, Sandra, Yen, Priscilla K., Boscardin, John, Hellmann, Jason, Spite, Matthew, Conte, Michael S. · 2015 · Journal of the American Heart Association
Cited by 84

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Background: Patients with peripheral artery disease ( PAD ) experience significant morbidity and mortality. The OMEGA ‐ PAD I Trial, a randomized, double‐blinded, placebo‐controlled trial, addressed the hypothesis that short‐duration, high‐dose n‐3 polyunsaturated fatty acids (n‐3 PUFA ) oral supplementation improves endothelial function and inflammation in PAD . Methods and Results: Eighty patients with stable claudication received 4.4 g of fish oil or placebo for 1 month. The primary end point was endothelial function as measured by brachial artery flow‐mediated vasodilation. Secondary end points included biomarkers of inflammation, n‐3 polyunsaturated fatty acids metabolome changes, lipid profile, and walking impairment questionnaires. Although there was a significant increase in FMD in the fish oil group following treatment (0.7±1.8% increase from baseline, P =0.04), this response was not different then the placebo group (0.6±2.5% increase from baseline, P =0.18; between‐group P =0.86) leading to a negative finding for the primary endpoint. There was, however, a significant reduction in triglycerides (fish oil: −34±46 mg/ dL , P <0.001; placebo −10±43 mg/ dL , P =0.20; between‐group differential P ‐value: 0.02), and an increase in the omega‐3 index of 4±1% ( P <0.001) in the fish oil group (placebo 0.1±0.9%, P =0.49; between‐group P <0.0001). We observed a significant increase in the production of pathway markers of specialized pro‐resolving mediators generated from n‐3 polyunsaturated fatty acids in the fish oil group. Conclusions: High‐dose, short‐duration fish oil supplementation did not lead to a different response in the primary end point of endothelial function between the treatment and placebo group, but improved serum triglycerides and increased the production of downstream n‐3 polyunsaturated fatty acids–derived products and mediators in patients with PAD . Clinical Trial Registration: URL : https://www.clinicaltrials.gov/ . Unique identifier: NCT 01310270.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/jaha.115.002034

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 84

Metadata

Authors
Grenon, S. M., Owens, C. D., Nosova, E. V., Hughes‐Fulford, M., Alley, H. F., Chong, K., Perez, S., Yen, P. K., Boscardin, J., Hellmann, J., Spite, M., & Conte, M. S.
Venue
Journal of the American Heart Association
Published
2015-08-25
Volume
4
Issue
8
Pages
e002034-e002034
ISSN
2047-9980 (ISSN-L)
OpenAlex
W2152230223
Cited by
84
References
20
FWCI
5.87
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short‐Term, High‐Dose Fish Oil Supplementation Increases the Production of Omega‐3 Fatty Acid–Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA‐PAD I Trial). https://app.cochat.ai/papers/10.1161/jaha.115.002034
The paper
Grenon, S. M., Owens, C. D., Nosova, E. V., Hughes‐Fulford, M., Alley, H. F., Chong, K., Perez, S., Yen, P. K., Boscardin, J., Hellmann, J., Spite, M., & Conte, M. S. (2015). Short‐Term, High‐Dose Fish Oil Supplementation Increases the Production of Omega‐3 Fatty Acid–Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA‐PAD I Trial). Journal of the American Heart Association. https://doi.org/10.1161/jaha.115.002034

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.